168 related articles for article (PubMed ID: 27460867)
1. The Molecular Mechanism of P2Y1 Receptor Activation.
Yuan S; Chan HC; Vogel H; Filipek S; Stevens RC; Palczewski K
Angew Chem Int Ed Engl; 2016 Aug; 55(35):10331-5. PubMed ID: 27460867
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Different Agonist-Binding Site and Activation Mechanism of the Human P2Y
Li Y; Yin C; Liu P; Li D; Lin J
Sci Rep; 2017 Oct; 7(1):13764. PubMed ID: 29062134
[TBL] [Abstract][Full Text] [Related]
3. Two disparate ligand-binding sites in the human P2Y1 receptor.
Zhang D; Gao ZG; Zhang K; Kiselev E; Crane S; Wang J; Paoletta S; Yi C; Ma L; Zhang W; Han GW; Liu H; Cherezov V; Katritch V; Jiang H; Stevens RC; Jacobson KA; Zhao Q; Wu B
Nature; 2015 Apr; 520(7547):317-21. PubMed ID: 25822790
[TBL] [Abstract][Full Text] [Related]
4. Distinct Signaling Patterns of Allosteric Antagonism at the P2Y
Gao ZG; Jacobson KA
Mol Pharmacol; 2017 Nov; 92(5):613-626. PubMed ID: 28864555
[TBL] [Abstract][Full Text] [Related]
5. BPTU, an allosteric antagonist of P2Y1 receptor, blocks nerve mediated inhibitory neuromuscular responses in the gastrointestinal tract of rodents.
Mañé N; Jiménez-Sábado V; Jiménez M
Neuropharmacology; 2016 Nov; 110(Pt A):376-385. PubMed ID: 27496690
[TBL] [Abstract][Full Text] [Related]
6. Different responses of the blockade of the P2Y1 receptor with BPTU in human and porcine intestinal tissues and in cell cultures.
Traserra S; Barber C; Maclnnes J; Relea L; MacPherson LC; Cunningham MR; Vergara P; Accarino A; Kennedy C; Jimenez M
Neurogastroenterol Motil; 2021 Jul; 33(7):e14101. PubMed ID: 33619847
[TBL] [Abstract][Full Text] [Related]
7. Demystifying P2Y
Ciancetta A; O'Connor RD; Paoletta S; Jacobson KA
J Chem Inf Model; 2017 Dec; 57(12):3104-3123. PubMed ID: 29182323
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
9. Platelet P2Y
Ribes A; Garcia C; Gratacap MP; Kostenis E; Martinez LO; Payrastre B; Sénard JM; Galés C; Pons V
BMC Biol; 2023 Feb; 21(1):14. PubMed ID: 36721118
[TBL] [Abstract][Full Text] [Related]
10. The Molecular Mechanism Underlying Ligand Binding to the Membrane-Embedded Site of a G-Protein-Coupled Receptor.
Yuan X; Raniolo S; Limongelli V; Xu Y
J Chem Theory Comput; 2018 May; 14(5):2761-2770. PubMed ID: 29660291
[TBL] [Abstract][Full Text] [Related]
11. Diadenosine tetraphosphate activates P2Y
Paquola A; Mañé N; Giron MC; Jimenez M
Eur J Pharmacol; 2019 Jul; 855():160-166. PubMed ID: 31063775
[TBL] [Abstract][Full Text] [Related]
12. P2Y1 Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells.
Rajasekhar P; Poole DP; Liedtke W; Bunnett NW; Veldhuis NA
J Biol Chem; 2015 Nov; 290(48):29051-62. PubMed ID: 26475857
[TBL] [Abstract][Full Text] [Related]
13. Diverse signalling of the platelet P2Y
Amison RT; Jamshidi S; Rahman KM; Page CP; Pitchford SC
Eur J Pharmacol; 2018 May; 827():58-70. PubMed ID: 29534999
[TBL] [Abstract][Full Text] [Related]
14. Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut.
Durnin L; Hwang SJ; Kurahashi M; Drumm BT; Ward SM; Sasse KC; Sanders KM; Mutafova-Yambolieva VN
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):15821-6. PubMed ID: 25341729
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of platelet P2Y
Arkless KL; Pan D; Shankar-Hari M; Amison RT; Page CP; Rahman KM; Pitchford SC
Br J Pharmacol; 2024 Feb; 181(4):564-579. PubMed ID: 36694432
[TBL] [Abstract][Full Text] [Related]
16. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
Yang W; Wang Y; Lai A; Qiao JX; Wang TC; Hua J; Price LA; Shen H; Chen XQ; Wong P; Crain E; Watson C; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
J Med Chem; 2014 Jul; 57(14):6150-64. PubMed ID: 24931384
[TBL] [Abstract][Full Text] [Related]
18. Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosis.
Le HTT; Murugesan A; Ramesh T; Yli-Harja O; Konda Mani S; Kandhavelu M
Int J Biol Macromol; 2021 Oct; 189():142-150. PubMed ID: 34425116
[TBL] [Abstract][Full Text] [Related]
19. Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs.
Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Lee JH
Neuropharmacology; 2014 Apr; 79():368-79. PubMed ID: 24333674
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide P2Y
Liston TE; Hinz S; Müller CE; Holstein DM; Wendling J; Melton RJ; Campbell M; Korinek WS; Suresh RR; Sethre-Hofstad DA; Gao ZG; Tosh DK; Jacobson KA; Lechleiter JD
Purinergic Signal; 2020 Dec; 16(4):543-559. PubMed ID: 33129204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
